Insider · CIK 0001033409

ESHELMAN FREDRIC N

Reports to the SEC for 10 companies · WILMINGTON, NC

sec.gov

Transactions

Companies

Filings

CIK

0001033409

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-10-24	Aravive, Inc.A Award	Director, Executive Chairman, 10% Owner	AAward	+16.3M sh	$0.92	+$15M	25,517,889
2022-10-24	Aravive, Inc.Series B Warrants (right to buy)A Award	Director, Executive Chairman, 10% Owner	AAward	+8.15M sh	—	—	8,153,060
2022-10-24	Aravive, Inc.Series A Warrants (right to buy)A Award	Director, Executive Chairman, 10% Owner	AAward	+8.15M sh	—	—	8,153,060
2022-09-23	Aravive, Inc.Stock Option (Right to Buy)A Award	Director, Executive Chairman, 10% Owner	AAward	+97.1K sh	—	—	97,063
2022-04-01	Aravive, Inc.Pre-Funded Warrant (right to buy)M Exercise/Conversion	Director, Executive Chairman, 10% Owner	MExercise/Conversion	+4.55M sh	—	—	0
2022-04-01	Aravive, Inc.M Exercise/Conversion	Director, Executive Chairman, 10% Owner	MExercise/Conversion	+4.55M sh	$0.00	+$454.546	9,211,769
2022-03-29	Aravive, Inc.A Award	Director, Executive Chairman, 10% Owner	AAward	+860K sh	$2.33	+$2M	4,666,314
2022-03-29	Aravive, Inc.Warrant (right to buy)A Award	Director, Executive Chairman, 10% Owner	AAward	+860K sh	$2.20	+$1.89M	860,216
2022-01-03	Aravive, Inc.Pre-Funded Warrant (right to buy)A Award	Director, Executive Chairman, 10% Owner	AAward	+4.55M sh	$2.20	+$10M	4,545,455
2021-11-17	HYPDHYPERION DEFI, INC. · Stock Option (right to buy)A Award	Director	AAward	+9,653 sh	—	—	9,653
2021-11-17	HYPDHYPERION DEFI, INC.A Award	Director	AAward	+6,963 sh	—	—	1,299,750
2021-09-10	Aravive, Inc.Stock OptionA Award	Director, Executive Chairman, 10% Owner	AAward	+22.8K sh	—	—	22,812
2021-02-12	Aravive, Inc.A Award	Director, Executive Chairman, 10% Owner	AAward	+2.88M sh	$7.29	+$21M	3,806,098
2020-09-14	Aravive, Inc.Stock OptionA Award	Director, Executive Chairman, 10% Owner	AAward	+16K sh	—	—	16,029
2020-09-11	HYPDHYPERION DEFI, INC.A Award	Director	AAward	+7,288 sh	—	—	1,292,787
2020-09-11	HYPDHYPERION DEFI, INC. · Stock Option (right to buy)A Award	Director	AAward	+9,820 sh	—	—	9,820
2020-06-11	G1 Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-06-01	Aravive, Inc.Stock OptionA Award	Director, Executive Chairman, 10% Owner	AAward	+7,500 sh	—	—	7,500
2020-06-01	Aravive, Inc.Stock OptionA Award	Director, Executive Chairman, 10% Owner	AAward	+3,226 sh	—	—	3,226
2019-08-16	HYPDHYPERION DEFI, INC.A Award	Director	AAward	+8,038 sh	—	—	1,285,499
2019-08-16	HYPDHYPERION DEFI, INC. · Stock Option (right to buy)A Award	Director	AAward	+9,057 sh	—	—	9,057
2019-06-12	G1 Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2018-07-24	HYPDHYPERION DEFI, INC.A Award	Director	AAward	+4,033 sh	—	—	1,277,461
2018-07-24	HYPDHYPERION DEFI, INC. · Stock Option (right to buy)A Award	Director	AAward	+4,465 sh	—	—	4,655
2018-06-07	G1 Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-05-31	MEDICINES CO /DEA Award	Director, Executive Chairman	AAward	+3,766 sh	—	—	1,132,149
2018-05-31	MEDICINES CO /DEStock Option (right-to-buy)A Award	Director, Executive Chairman	AAward	+14.1K sh	—	—	14,141
2018-01-29	HYPDHYPERION DEFI, INC.P Purchase	Director	PPurchase	+335K sh	$10.00	+$3.35M	1,273,428
2017-12-08	MEDICINES CO /DEP Purchase	Director, Executive Chairman	PPurchase	+100K sh	$26.65	+$2.67M	1,128,383
2017-12-07	MEDICINES CO /DEP Purchase	Director, Executive Chairman	PPurchase	+100K sh	$26.46	+$2.65M	1,028,383
2017-11-13	G1 Therapeutics, Inc.P Purchase	Director	PPurchase	+250K sh	$19.73	+$4.93M	250,000
2017-07-11	G1 Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2017-05-25	MEDICINES CO /DEA Award	Director, Executive Chairman	AAward	+3,237 sh	—	—	928,383
2017-05-25	MEDICINES CO /DEStock Option (right-to-buy)A Award	Director, Executive Chairman	AAward	+13.6K sh	—	—	13,577
2017-05-22	G1 Therapeutics, Inc.P Purchase	Director	PPurchase	+300K sh	$15.00	+$4.5M	3,439,151
2017-05-22	G1 Therapeutics, Inc.Series C Preferred StockC Conversion	Director	CConversion	−2.52M sh	—	—	0
2017-05-22	G1 Therapeutics, Inc.C Conversion	Director	CConversion	+3.14M sh	—	—	3,139,151
2017-05-22	G1 Therapeutics, Inc.Series B Preferred StockC Conversion	Director	CConversion	−6.89M sh	—	—	0
2017-05-05	BHCBausch Health Companies Inc.A Award	Director	AAward	+25.4K sh	—	—	38,298
2017-05-03	BHCBausch Health Companies Inc.F Tax Payment	Director	FTax Payment	−4,904 sh	$9.66	−$47.4K	12,892
2016-12-08	MEDICINES CO /DEP Purchase	Director, Executive Chairman	PPurchase	+19.2K sh	$32.51	+$624K	919,645
2016-12-08	MEDICINES CO /DEP Purchase	Director, Executive Chairman	PPurchase	+5,501 sh	$33.19	+$183K	925,146
2016-12-07	MEDICINES CO /DEP Purchase	Director, Executive Chairman	PPurchase	+86.6K sh	$32.90	+$2.85M	900,457
2016-12-07	MEDICINES CO /DEP Purchase	Director, Executive Chairman	PPurchase	+173K sh	$33.61	+$5.81M	813,870
2016-12-06	MEDICINES CO /DEP Purchase	Director, Executive Chairman	PPurchase	+338K sh	$34.15	+$11.5M	641,106
2016-07-01	BHCBausch Health Companies Inc.F Tax Payment	Director	FTax Payment	−26 sh	$23.78	−$618.28	17,796
2016-06-17	BHCBausch Health Companies Inc.A Award	Director	AAward	+16.7K sh	—	—	17,822
2016-05-26	MEDICINES CO /DEStock Option (right-to-buy)A Award	Director, Executive Chairman	AAward	+14.7K sh	—	—	14,700
2016-05-26	MEDICINES CO /DEA Award	Director, Executive Chairman	AAward	+3,426 sh	—	—	303,426
2016-05-12	MEDICINES CO /DEP Purchase	Director, Executive Chairman	PPurchase	+300K sh	$33.68	+$10.1M	300,000

Recent filings

Accepted (ET)
Oct 264
ESHELMAN FREDRIC N0001437749-22-024809
SEC(opens sec.gov)
Sep 264
ESHELMAN FREDRIC N0001437749-22-023058
SEC(opens sec.gov)
Apr 44
ESHELMAN FREDRIC N0001437749-22-008178
SEC(opens sec.gov)
Mar 314
ESHELMAN FREDRIC N0001437749-22-007849
SEC(opens sec.gov)
Jan 54
ESHELMAN FREDRIC N0001437749-22-000442
SEC(opens sec.gov)
Nov 224
ESHELMAN FREDRIC N0001415889-21-005365
SEC(opens sec.gov)
Sep 134
ESHELMAN FREDRIC N0001437749-21-022039
SEC(opens sec.gov)
Feb 174
ESHELMAN FREDRIC N0000899243-21-006977
SEC(opens sec.gov)
Sep 154
ESHELMAN FREDRIC N0000899243-20-025114
SEC(opens sec.gov)
Sep 154
ESHELMAN FREDRIC N0001104659-20-105231
SEC(opens sec.gov)
Jun 124
ESHELMAN FREDRIC N0001209191-20-036290
SEC(opens sec.gov)
Jun 34
ESHELMAN FREDRIC N0000899243-20-015044
SEC(opens sec.gov)
Aug 204
ESHELMAN FREDRIC N0001638599-19-000798
SEC(opens sec.gov)

Companies

Address

929 NORTH FRONT STREET

WILMINGTON, NC, 28401